On the occasion of the 43rd J.P. Morgan Healthcare Conference in San Francisco, Bayer AG announces further progress in its pharmaceutical growth strategy with multiple regulatory filing submissions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback